Startups
Founded in 2013 by Dan Doctoroff, Target ALS is a medical research foundation whose mission is to acc
Overview
Location
United States, New York
Employees
11-50
Phone
+1 332-333-4140
Founded date
2013
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 6, 2024 | NRG Therapeutics Awarded Grant Funding from Target ALS to Support the Development of mPTP Inhibitors as Novel Treatments for ALS/MND | Stevenage, UK, 5 September 2024 – NRG Therapeutics, Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, is pleased to announce that it has been awarded a non-dilutive grant from Target ALS Foundation. It is one of ... |
| May 7, 2024 | Target ALS Achieves Extraordinary $250 Million Capital Campaign Goal to Accelerate ALS Research | NEW YORK, May 7, 2024 /PRNewswire/ -- Target ALS is thrilled to announce that it has reached its $250 million capital campaign goal, spearheaded by visionary founder, Dan Doctoroff. After his diagnosis with ALS in late 2021, Dan focused his... |
| Dec 21, 2021 | Alzheimer’s Drug Discovery Foundation (ADDF) and Target ALS Announce Partnership to Accelerate Biomarker Discovery and Development | ADDF and Target ALS Partner to Accelerate Biomarker Discovery and Development NEW YORK (PRWEB) December 21, 2021 The Alzheimer’s Drug Discovery Foundation (ADDF) and Target ALS announced today a new partnership to identify and develop bioma... |
| Sep 14, 2021 | QurAlis Announces Development Candidate for ALS Targeting STATHMIN-2 | QRL-201 is a first-in-class molecule that rescues STATHMIN-2 loss of function in motor neuron disease models in the presence of TDP43 pathology |
| Dec 15, 2020 | Target ALS Announces Second Round of 2020 Grant Recipients Focused on Discovering and Developing ALS Biomarkers | The Target ALS Diagnosis Initiative We are now at a juncture where reliable biomarkers are an increasingly acute need. We look forward to the contribution of these consortia in this search, which could greatly improve the lives of ALS patie... |
Reviews 0
FAQ about Target ALS
When was Target ALS founded?
Target ALS was founded in 2013.
What has the press written about Target ALS?
Parsers VC has collected 6 articles mentioning Target ALS, among them “NRG Therapeutics Awarded Grant Funding from Target ALS to Support the Development of mPTP Inhibitors as Novel Treatments for ALS/MND” (Sep 6, 2024) and “Target ALS Achieves Extraordinary $250 Million Capital Campaign Goal to Accelerate ALS Research” (May 7, 2024).
Is Target ALS still active?
Yes, Target ALS is active; its latest activity on Parsers VC dates from Sep 30, 2024.